Enhancement of survivin-specific anti-tumor immunity by adenovirus prime protein-boost immunity strategy with DDA/MPL adjuvant in a murine melanoma model. [electronic resource]
Producer: 20140203Description: 9-17 p. digitalISSN:- 1878-1705
- Adjuvants, Immunologic
- Animals
- Cancer Vaccines
- Cell Line
- Cell Proliferation
- Female
- Humans
- Inhibitor of Apoptosis Proteins -- genetics
- Lipid A -- administration & dosage
- Melanoma -- immunology
- Mice
- Mice, Inbred C57BL
- Neoplasms, Experimental
- Organoplatinum Compounds
- Oxaliplatin
- Quaternary Ammonium Compounds -- administration & dosage
- Specific Pathogen-Free Organisms
- Survivin
- T-Lymphocyte Subsets
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.